$198 Million is the total value of Golden State Equity Partners's 175 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PHM | New | PULTE GROUP INC | $1,272,000 | – | 22,252 | +100.0% | 0.64% | – |
| T | New | AT&T INC | $1,241,000 | – | 50,465 | +100.0% | 0.63% | – |
| DD | New | DUPONT DE NEMOURS INC | $908,000 | – | 11,235 | +100.0% | 0.46% | – |
| PNC | New | PNC FINL SVCS GROUP INC | $649,000 | – | 3,237 | +100.0% | 0.33% | – |
| AES | New | AES CORP | $641,000 | – | 26,362 | +100.0% | 0.32% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $635,000 | – | 952 | +100.0% | 0.32% | – |
| GM | New | GENERAL MTRS CO | $551,000 | – | 9,405 | +100.0% | 0.28% | – |
| BEAM | New | BEAM THERAPEUTICS INC | $526,000 | – | 6,600 | +100.0% | 0.27% | – |
| SYY | New | SYSCO CORP | $521,000 | – | 6,635 | +100.0% | 0.26% | – |
| DKS | New | DICKS SPORTING GOODS INC | $487,000 | – | 4,236 | +100.0% | 0.25% | – |
| CDNS | New | CADENCE DESIGN SYSTEM INC | $376,000 | – | 2,020 | +100.0% | 0.19% | – |
| NVTA | New | INVITAE CORP | $355,000 | – | 23,225 | +100.0% | 0.18% | – |
| SHYG | New | ISHARES TR0-5yr hi yl cp | $355,000 | – | 7,831 | +100.0% | 0.18% | – |
| MKSI | New | MKS INSTRS INC | $336,000 | – | 1,932 | +100.0% | 0.17% | – |
| TROW | New | PRICE T ROWE GROUP INC | $325,000 | – | 1,652 | +100.0% | 0.16% | – |
| CCL | New | CARNIVAL CORP | $318,000 | – | 15,804 | +100.0% | 0.16% | – |
| GPN | New | GLOBAL PMTS INC | $307,000 | – | 2,273 | +100.0% | 0.16% | – |
| LEVI | New | LEVI STRAUSS & CO NEW | $303,000 | – | 12,095 | +100.0% | 0.15% | – |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $299,000 | – | 18,730 | +100.0% | 0.15% | – |
| PGR | New | PROGRESSIVE CORP | $296,000 | – | 2,888 | +100.0% | 0.15% | – |
| ZYME | New | ZYMEWORKS INC | $292,000 | – | 17,793 | +100.0% | 0.15% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $278,000 | – | 12,325 | +100.0% | 0.14% | – |
| LRMR | New | LARIMAR THERAPEUTICS INC | $270,000 | – | 25,015 | +100.0% | 0.14% | – |
| EWBC | New | EAST WEST BANCORP INC | $262,000 | – | 3,335 | +100.0% | 0.13% | – |
| BDX | New | BECTON DICKINSON & CO | $231,000 | – | 920 | +100.0% | 0.12% | – |
| BSCO | New | INVESCO EXCH TRD SLF IDX FD | $226,000 | – | 10,373 | +100.0% | 0.11% | – |
| LIN | New | LINDE PLC | $223,000 | – | 644 | +100.0% | 0.11% | – |
| NOC | New | NORTHROP GRUMMAN CORP | $218,000 | – | 564 | +100.0% | 0.11% | – |
| ENB | New | ENBRIDGE INC | $212,000 | – | 5,421 | +100.0% | 0.11% | – |
| AVTE | New | AEROVATE THERAPEUTICS INC | $188,000 | – | 15,930 | +100.0% | 0.10% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $158,000 | – | 11,435 | +100.0% | 0.08% | – |
| CNTA | New | CENTESSA PHARMACEUTICALS PLCsponsored ads | $156,000 | – | 13,870 | +100.0% | 0.08% | – |
| TLIS | New | TALIS BIOMEDICAL CORP | $89,000 | – | 22,133 | +100.0% | 0.04% | – |
| CLSD | New | CLEARSIDE BIOMEDICAL INC | $84,000 | – | 30,527 | +100.0% | 0.04% | – |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $55,000 | – | 10,505 | +100.0% | 0.03% | – |
| CKPT | New | CHECKPOINT THERAPEUTICS INC | $41,000 | – | 13,100 | +100.0% | 0.02% | – |
| LPTX | New | LEAP THERAPEUTICS INC | $38,000 | – | 11,650 | +100.0% | 0.02% | – |
| BNGO | New | BIONANO GENOMICS INC | $36,000 | – | 12,037 | +100.0% | 0.02% | – |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $32,000 | – | 20,300 | +100.0% | 0.02% | – |
| ORTX | New | ORCHARD THERAPEUTICS PLCads | $28,000 | – | 21,450 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC | 9 | Q3 2023 | 7.0% |
| MICROSOFT CORP | 9 | Q3 2023 | 5.0% |
| ALPHABET INC | 9 | Q3 2023 | 3.1% |
| HARTFORD FDS EXCHANGE TRADED | 9 | Q3 2023 | 4.4% |
| SPDR SER TR | 9 | Q3 2023 | 3.2% |
| AMAZON COM INC | 9 | Q3 2023 | 3.5% |
| WISDOMTREE TR | 9 | Q3 2023 | 4.5% |
| RTX CORPORATION | 9 | Q3 2023 | 2.2% |
| FIRST TR EXCH TRADED FD III | 9 | Q3 2023 | 2.5% |
| FIRST TR EXCH TRADED FD III | 9 | Q3 2023 | 2.4% |
View Golden State Equity Partners's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-10-20 |
| 13F-HR | 2023-07-19 |
| 13F-HR | 2023-06-01 |
| 13F-HR/A | 2022-05-18 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-13 |
View Golden State Equity Partners's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.